Developing tools to combat infectious diseases and prepare for pandemics
UofL RBL Operations, Workforce Development and Pandemic Preparedness Research
This study is all about making better tests, treatments, and vaccines for new infectious diseases, like COVID-19, so that we can be more prepared for future health crises, and it aims to help patients by improving how we prevent and treat these illnesses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-10910200 on NIH RePORTER |
What this research studies
This research focuses on enhancing the capabilities of the University of Louisville Regional Biocontainment Laboratory to develop diagnostics, therapeutics, and vaccines aimed at addressing emerging infectious diseases, particularly in response to public health crises like COVID-19. The laboratory operates specialized facilities designed for high-risk pathogens, allowing for safe and effective research. By leveraging past experiences with pandemics and biological threats, the research aims to improve preparedness and response strategies for future outbreaks. Patients may benefit from advancements in treatment and prevention methods that arise from this research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals affected by or at risk for infectious diseases, particularly those related to COVID-19.
Not a fit: Patients with non-infectious diseases or those not impacted by emerging infectious diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostics and treatments for infectious diseases, enhancing public health safety.
How similar studies have performed: Previous research in biocontainment and pandemic preparedness has shown success in developing effective responses to infectious disease outbreaks.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Palmer, Kenneth E — University of Louisville
- Study coordinator: Palmer, Kenneth E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.